. Author manuscript; available in PMC: 2021 Oct 1.

Published in final edited form as: Neurorehabil Neural Repair. 2021 Feb 12;35(4):307–320. doi: 10.1177/1545968321992330

Table 2. Participant demographics and clinical characteristics.

Note, statistical values compare data between the ipsilesional dataset and contralesional dataset. Statistically significant differences are shown in bold.

ARAT, action research arm test; FM-UE, Fugl Meyer Upper Extremity; NIHSS, National Institutes of Health Stroke Scale; rtPA, recombinant tissue plasminogen activator.

	Ipsilesional	Contralesional	Group	Statistics

Age (mean ± SD)	66.6 ± 17.8	68.2 ± 9.8	67.4 ± 14.4	t ₍₅₈₎ = 0.44, p = 0.66
*Years*	(range 26-93)	(range 46-82)	(range 26-93)
Sex				χ² = 0.43, p = 0.59
Male (n)	20	21	41
Female (n)	11	8	19
Lesioned hemisphere				χ² = 1.72, p = 0.21
Right (n)	17	11	28
Left (n)	14	18	32
rtPA treated
yes, n (%)	10 (32%)	8 (27%)	18 (30%)	χ² = 0.16, p = 0.78
NIHSS (mean ± SD)	6.7 ± 4.9	3.9 ± 2.7	5.4 ± 4.2	t₍₅₈₎ = 2.75, p = 0.008
	(range 1-17)	(range 1-12)	(range 1-17)
ARAT at baseline	48.0 ± 14.0	-	-	-
(mean ± SD)	(range 8-57)
FM-UE at baseline	-	61.8 ± 2.9	-	-
(mean ± SD)		(range 56-66)